Just Answers - Finance

It was a shaky hand for the buyers, indeed. First the market went quiet and lulled the short sellers to sleep. Then it had a quick ten minute rally that stopped

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

them out for a loss. Next, the market did a clever thing. It caught the “longer term” futures traders who were still short. The advance-decline line was still do

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

n around 2:1 negative AFTER the initial rally. This can happen since it takes time for stocks to get up past “unchanged” for the day.

I noticed the latest cycle

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

changed character and bottomed out early. It made an early bottom with right translation, which is bullish. This is like trying to hold back a stressed dam. When

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

the cycles bottom early, there’s no stopping the next move. The futures market cleverly crept slowly higher to disguise its next move. This gave more eager trad

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

rs plenty of opportunities to get short. But, it was stingy when it came to letting it be bought. Does that tell you another bullish clue?

The next move up was

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

reathtaking. The market fulfilled its job of rewarding the traders with the shaky hands. The commodity traders that caught the falling daggers earlier were now s

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

miling. But the comfortable short traders who thought they had a sure thing were in shock.

To become a better futures contract trader, spend time developing you

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

own ideas of what makes a vulnerable market situation. The market has many ways to lure traders into thinking they are in a safe trade. I know a few smart trade

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

s who use simple trend lines and moving averages. Why? They use them to see what the majority is seeing and exploit the failures. It’s the same with basic moment

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

m indicators. All this stuff works when the markets are acting normally. But the times when these commonly used indicators fail are when the fast panics occur. Y

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ou can sometimes make a few days pay in minutes.

I talk about market "snuffs" in one of my free Thomas Commodity Trading Course lessons on the S&P 500. This is

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

xactly what vulnerability is all about. It's the majority expecting a futures market turn to occur, but the turn fails and price continues in the same direction.

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

It’s the reverse energy of a cycle failure. Or it’s the move when the momentum bottom fails to turn a market. Or it’s a broken trend line that has been in effect

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

for a long time. Remember that these failures work in the minority of cases. You have to be selective and have other evidence supporting them.

All major turnin

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

points start out with sharp moves as viewed from the smaller degrees of price action. This is the “kick-off.” Whatever time frame you are looking at, there is a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

micro and macro, from one small tick to centuries long.

Always be aware of the context or degree of price action you are studying when trying to exploit failure

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

s. If you are studying a minor turn, which later turns out to be a major turn, the futures price action within the minor turn will be much amplified and distorte

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

. Use these clues to access what you may be dealing with in the future. It can give you information of how much strength or weakness to expect in the next move.

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

Good Trading!

There is substantial risk of loss trading futures and options and may not be suitable for all types of investors. Only risk capital should be used

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/116766/justanswers-Commodity-Trading--Stay-Out-Of-Safe-Trades--PART-3--Do-You-Make-These-Common-Novice-Mistakes.html">Commodity Trading - Stay Out Of 'Safe' Trades - PART 3 - Do You Make These Common Novice Mistakes?</a>

BB link (for phorums):
[url=http://www.justanswers.org.ua/article/116766/justanswers-Commodity-Trading--Stay-Out-Of-Safe-Trades--PART-3--Do-You-Make-These-Common-Novice-Mistakes.html]Commodity Trading - Stay Out Of 'Safe' Trades - PART 3 - Do You Make These Common Novice Mistakes?[/url]

Over the years, business attire has changed significantly. Because of the sudden change in business dress code it is sometimes difficult to draw the line between what’s acceptable and what’s unacceptable. Business wear in the traditional sense is stringent. Traditional business attire, for men, purely consists of wearing a dress suit. This includes wearing a matching coat and slacks, a long sleeved dress shirt, a necktie, and dress shoes.

Anyone seeking work in the computer services industry will need an information technology resume. I've included a link to a sample resume at the bottom of the article. This resume can be used as reference when writing your own.

People don’t realize how powerful rumors and speculation can be, it’s basically like getting an exclusive story, except it’s unconfirmed, or based on a dodgy source.

Tags

Links

Just Answers - Commodity Trading - Stay Out Of 'Safe' Trades - PART 3 - Do You Make These Common Novice Mistakes?

Related Articles: